Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7373 p540
29 October 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Society may charge PCTs for fitness checks

The Royal Pharmaceutical Society may consider charging primary care trusts for checking the fitness to practise of pharmacists applying to join pharmaceutical services supplementary lists.

In its comments (PDF 100K) on “Modernising the regulation of primary care — NHS (Pharmaceutical Services Supplementary List) regulations 2005”, The Society says that PCTs need to be provided with advice on how deep the fitness-to-practise check needs to go. “This should be given careful consideration in order to minimise the impact on the Societ. Alternatively, the Society will need to give consideration to charging a fee for requests made,” it adds.

The Society is also warning that investigation of serious fitness-to-practise issues by PCTs and the Society may lead to a duplication of effort. “It is therefore important that PCTs are permitted to place reliance on the Society’s regulatory role in the most serious cases,” it says.

Concerns have also been raised about the absence of any provision in the draft regulations for pharmacists who work in more than one PCT area to register in a home PCT or for pharmacists to work in more than one home country without incurring an administrative burden.

The Society warns, too, that the omission of ill health from the list of impairments to practise is a serious omission and that the regulations need to be clear that they define a pharmacist as someone on the practising register.

Regulatory framework review Regulation and inspection in health and social care are to be subject to a wide-ranging review, the Department of Health announced last week. The review will define the DoH’s objectives in regulation and inspection. However, it will not encompass regulation of individuals.

The review is expected to be presented to ministers by Christmas.

Back to Top


©The Pharmaceutical Journal